微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 1.83% | -43.17% | 77.67% | 100/159 | 4.19% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 1.03% | -37.95% | 114.58% | 99/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.48% | -29.41% | -87.17% | 106/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 3.74% | -38.69% | 16.15% | 73/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 3.22% | -22.22% | 93.98% | 83/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.66% | -19.42% | 144.12% | 87/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.68% | -40.87% | -88.85% | 91/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 6.1% | 9.12% | 47.34% | 51/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.14% | -13.21% | 100.97% | 72/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.06% | 15.73% | 79.13% | 82/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.15% | -23.84% | -79.43% | 88/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.59% | 116.67% | 17.19% | 60/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.77% | 56.39% | 167.98% | 73/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.78% | -1.66% | 17.88% | 88/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.51% | -7.93% | -41.47% | 70/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.58% | 104.76% | -15.41% | 95/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.05% | 376.56% | 68.51% | 84/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.81% | 56.03% | 10.37% | 91/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.64% | 69.07% | 30.16% | 69/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.26% | 223.08% | 96.88% | 104/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 0.64% | 3100% | -44.83% | 113/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.16% | -52.85% | 19.59% | 108/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.97% | 286.54% | 148.72% | 94/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.39% | -87.85% | 1850% | 107/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 0.02% | -99.57% | -99.19% | 100/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.46% | -15.17% | 573.08% | 82/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | -0.52% | -133.33% | -116.2% | 90/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.21% | 134.31% | -31.12% | 101/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.66% | -25.32% | 60.69% | 70/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.9% | -31.6% | 85.9% | 72/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.56% | -26.42% | 13.87% | 66/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.37% | -71.58% | -78.04% | 113/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.24% | 84.07% | 47.17% | 52/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.24% | 202.86% | 100% | 52/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.12% | 351.06% | -56.02% | 50/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.82% | 1083.67% | 42.18% | 85/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.39% | 1155.56% | 142.14% | 71/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.4% | 766.67% | 197.87% | 86/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.47% | 361.11% | 195.92% | 75/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | -0.49% | 96.78% | -281.48% | 105/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.27% | 103.1% | 228.57% | 78/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | -0.21% | 93.9% | -16.67% | 83/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -0.18% | 84.62% | 98.82% | 76/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |